Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 695-704

  Jamnongkan, Wassana ^a,b   Techasen, Anchalee ^a,b   Thanan, Raynoo ^a,b   Duenngai, Kunyarat ^b   Sithithaworn, Paiboon ^a,b   Mairiang, Eimorn ^a   Loilome, Watcharin ^a,b   Namwat, Nisana ^a,b   Pairojkul, Chawalit ^a,b   Yongvanit, Puangrat ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Opisthorchis viverrini; Oxidized alpha 1 antitrypsin; Periductal fibrosis; Risk marker

Indexed keywords

ALPHA 1 ANTITRYPSIN; OXIDIZED ALPHA 1 ANTITRYPSIN; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT FIBROSIS; BLOOD LEVEL; CANCER PROGNOSIS; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; ANIMAL; BILE DUCT TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; INTRAHEPATIC BILE DUCT; METABOLISM; MIDDLE AGED; MORTALITY; OPISTHORCHIS; OXIDATION REDUCTION REACTION; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; WESTERN BLOTTING;

ADULT; ALPHA 1-ANTITRYPSIN; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OPISTHORCHIASIS; OPISTHORCHIS; OXIDATION-REDUCTION; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877140225     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0597-7     Document Type: Article

References (27)

1. Sriplung H, Wiangnon S, Sontipong S, Sumitsawan Y, Martin N. Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev. 2006;7(2):239-44.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-44.
3. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. Parasitol Int. 2012;61(1):10-6.
4. Yongvanit P, Pinlaor S, Bartsch H. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int. 2012;61(1):130-5.
5. Yongvanit P, Thanan R, Pinlaor S, Sithithaworn P, Loilome W, Namwat N, et al. Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. Parasitol Res. 2012;110(5):1969-77.
6. Pinlaor S, Ma N, Hiraku Y, Yongvanit P, Semba R, Oikawa S, et al. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis. 2004;25(8):1535-42.
7. Pinlaor S, Sripa B, Sithithaworn P, Yongvanit P. Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. Exp Parasitol. 2004;108(1-2):32-9.
8. Boonmars T, Srisawangwong T, Srirach P, Kaewsamut B, Pinlaor S, Sithithaworn P. Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel. Parasitol Res. 2007;102(1):57-62.
9. Boonmars T, Srirach P, Kaewsamut B, Srisawangwong T, Pinlaor S, Pinlaor P, et al. Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment. Parasitol Res. 2008;102(3):447-55.
10. Prakobwong S, Pinlaor S, Yongvanit P, Sithithaworn P, Pairojkul C, Hiraku Y. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol. 2009;39(7):825-35.
11. Mairiang E, Elkins DB, Mairiang P, Chaiyakum J, Chamadol N, Loapaiboon V, et al. Relationship between intensity of Opisthorchis viverrini infection and hepatobiliary disease detected by ultrasonography. J Gastroenterol Hepatol. 1992;7(1):17-21.
12. Mairiang E, Laha T, Bethony JM, Thinkhamrop B, Kaewkes S, Sithithaworn P, et al. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int. 2012;61(1):208-11.
13. Thanan R, Oikawa S, Yongvanit P, Hiraku Y, Ma N, Pinlaor S. Inflammation-induced protein carbonylation contributes to poor prognosis of cholangiocarcinoma. Free Rad Biol Med. 2012.
14. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, et al. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem. 2000;275(35):27258-65.
15. Banfi C, Brioschi M, Barcella S, Veglia F, Biglioli P, Tremoli E, et al. Oxidized proteins in plasma of patients with heart failure: role in endothelial damage. Eur J Heart Fail. 2008;10(3):244-51.
16. Sripa B, Mairiang E, Thinkhamrop B, Laha T, Kaewkes S, Sithithaworn P, et al. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology. 2009;50(4):1273-81.
17. Boonjaraspinyo S, Boonmars T, Wu Z, Loilome W, Sithithaworn P, Nagano I, et al. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. Tumour Biol. 2012;33(5):1785-802.
18. Loilome W, Yooyuen S, Namwat N, Sithithaworn P, Puapairoj A, Kano J, et al. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. Tumour Biol. 2012;33(6):2289-98.
19. Van Beers BE. Diagnosis of cholangiocarcinoma. HPB (Oxford). 2008;10(2):87-93.
20. Chidwick K, Winyard PG, Zhang Z, Farrell AJ, Blake DR. Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis. 1991;50(12):915-6.
21. Sepper R, Konttinen YT, Ingman T, Sorsa T. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis. J Clin Immunol. 1995;15(1):27-34.
22. Ueda M, Mashiba S, Uchida K. Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibody. Clin Chim Acta. 2002;317(1-2):125-31.
23. Izumi-Yoneda N, Toda A, Okabe M, Koike C, Takashima S, Yoshida T, et al. Alpha 1 antitrypsin activity is decreased in human amnion in premature rupture of the fetal membranes. Mol Hum Reprod. 2009;15(1):49-57.
24. Mannello F, Gazzanelli G. Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis. 2001;6(6):479-82.
25. Remacle A, McCarthy K, Noel A, Maguire T, McDermott E, O'Higgins N, et al. High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer. 2000;89(2):118-21.
26. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001;189(2):197-206.
27. Leelawat K, Sakchinabut S, Narong S, Wannaprasert J. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy. BMC Gastroenterol. 2009;9:30.